Apogee Therapeutics, Inc. (APGE)
135.07
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
Apogee Therapeutics Market Cap : 10.18B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 10.18B |
| September 10, 2026 | 10.18B |
| September 09, 2026 | 10.18B |
| September 08, 2026 | 10.18B |
| September 04, 2026 | 10.18B |
| September 03, 2026 | 10.18B |
| September 02, 2026 | 10.18B |
| September 01, 2026 | 10.18B |
| August 31, 2026 | 10.18B |
| August 28, 2026 | 10.17B |
| August 27, 2026 | 10.17B |
| August 26, 2026 | 10.17B |
| August 25, 2026 | 10.16B |
| August 24, 2026 | 10.16B |
| August 21, 2026 | 10.15B |
| August 20, 2026 | 10.15B |
| August 19, 2026 | 10.15B |
| August 18, 2026 | 10.14B |
| August 17, 2026 | 10.14B |
| August 14, 2026 | 10.14B |
| August 13, 2026 | 10.13B |
| August 12, 2026 | 10.14B |
| August 11, 2026 | 10.15B |
| August 10, 2026 | 10.14B |
| August 07, 2026 | 10.16B |
| Date | Value |
|---|---|
| August 06, 2026 | 10.13B |
| August 05, 2026 | 10.11B |
| August 04, 2026 | 10.05B |
| August 03, 2026 | 10.04B |
| July 31, 2026 | 10.04B |
| July 30, 2026 | 10.06B |
| July 29, 2026 | 10.05B |
| July 28, 2026 | 10.05B |
| July 27, 2026 | 10.06B |
| July 24, 2026 | 10.06B |
| July 23, 2026 | 10.05B |
| July 22, 2026 | 10.04B |
| July 21, 2026 | 10.05B |
| July 20, 2026 | 10.05B |
| July 17, 2026 | 10.03B |
| July 16, 2026 | 10.04B |
| July 15, 2026 | 10.06B |
| July 14, 2026 | 10.03B |
| July 13, 2026 | 10.02B |
| July 10, 2026 | 10.01B |
| July 09, 2026 | 10.00B |
| July 08, 2026 | 9.978B |
| July 07, 2026 | 10.000B |
| July 06, 2026 | 9.997B |
| July 02, 2026 | 9.953B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Intellia Therapeutics, Inc. | 1.644B |
| Cogent Biosciences, Inc. | 5.735B |
| Revolution Medicines, Inc. | 43.66B |
| Moderna, Inc. | 57.44B |
Market Cap Related Metrics
| PEG Ratio | -4.897 |
| Price to Book Value | 8.518 |
| Price | 135.07 |
| Earnings Yield | -3.21% |
| PEGY Ratio | -4.897 |